Interleukin 13 increases contractility of murine tracheal smooth muscle by a phosphoinositide 3-kinase p110δ-dependent mechanism

Molecular Pharmacology

Volumn 73, Issue 5, 2008, Pages 1530-1537

  Farghaly, Hanan S M ^a   Blagbrough, Ian S ^a   Medina Tato, David A ^a   Watson, Malcolm L ^a  

^a University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (6 AMINO 9 PURINYLMETHYL) 5 METHYL 3 (2 METHYLPHENYL) 3H QUINAZOLIN 4 ONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CARBACHOL; INTERLEUKIN 13; PHOSPHATIDYLINOSITOL 3 KINASE; POTASSIUM CHLORIDE; PROTEIN KINASE B; WORTMANNIN; 1 PHOSPHATIDYLINOSITOL 3 KINASE P110 SUBUNIT, MOUSE; 1-PHOSPHATIDYLINOSITOL 3-KINASE P110 SUBUNIT, MOUSE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ADENINE; CHROMONE DERIVATIVE; DRUG DERIVATIVE; ISOENZYME; MORPHOLINE DERIVATIVE; MUTANT PROTEIN; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE; TISSUE EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CATALYSIS; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVATION; FEMALE; MALE; MOUSE; MUSCLE CONTRACTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRACHEA MUSCLE; ANIMAL; BRONCHUS HYPERREACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; IN VITRO STUDY; LUNG; METABOLISM; MOUSE MUTANT; PHOSPHORYLATION; SMOOTH MUSCLE; TRACHEA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENINE; ANIMALS; BRONCHIAL HYPERREACTIVITY; CARBACHOL; CHROMONES; INTERLEUKIN-13; ISOENZYMES; LUNG; MICE; MICE, MUTANT STRAINS; MORPHOLINES; MUSCLE CONTRACTION; MUSCLE, SMOOTH; MUTANT PROTEINS; PHOSPHORYLATION; POTASSIUM CHLORIDE; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; QUINAZOLINES; TISSUE EXTRACTS; TRACHEA;

EID: 42449116645     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.045419     Document Type: Article

References (39)

1. Adner M, Rose AC, Zhang Y, Sward K, Benson M, Uddman R, Shankley NP, and Cardell LO (2002) An assay to evaluate the long-term effects of inflammatory mediators on murine airway smooth muscle: evidence that TNF alpha upregulates 5-HT2A-mediated contraction. Br J Pharmacol 137:971-982.
2. Ceponis PJ, Botelho F, Richards CD, and Mckay DM (2000) Interleukins 4 and 13 increase intestinal epithelial permeability by a phosphatidylinositol 3-kinase pathway - lack of evidence for STAT 6 involvement. J Biol Chem 275:29132-29137.
3. Davies SP, Reddy H, Caivano M, and Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95-105.
4. Deshpande DA, Dogan S, Walseth TF, Miller SM, Amrani Y, Panettieri RA, and Kannan MS (2004) Modulation of calcium signaling by interleukin-13 in human airway smooth muscle - role of CD38/cyclic adenosine diphosphate ribose pathway. Am J Respir Cell Mol Biol 31:36-42.
5. Duan W, Aguinaldo Datiles AM, Leung BP, Vlahos CJ, and Wong WS (2005) An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model. Int Immunopharmacol 5:495-502.
6. Eum SY, Maghni K, Tolloczko B, Eidelman DH, and Martin JG (2005) IL-13 may mediate allergen-induced hyperresponsiveness independently of IL-5 or eotaxin by effects on airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 288:L576-L584.
7. Ezeamuzie CI, Sukumaran J, and Philips E (2001) Effect of wortmannin on human eosinophil responses in vitro and on bronchial inflammation and airway hyperresponsiveness in guinea pigs in vivo. Am J Respir Crit Care Med 164:1633-1639.
8. Fredberg JJ (2004) Bronchospasm and its biophysical basis in airway smooth muscle. Respir Res 5:2.
9. Grünig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, et al. (1998) Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282:2261-2263.
10. Grunstein MM, Hakonarson H, Leiter J, Chen M, Whelan R, Grunstein JS, and Chuang S (2002) IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 282:L520-L528.
11. Hajoui O, Janani R, Tulic M, Joubert P, Ronis T, Hamid Q, Zheng H, and Mazer BD (2004) Synthesis of IL-13 by human B lymphocytes: Regulation and role in IgE production. J Allergy Clin Immunol 114:657-663.
12. Hershey GK (2003) IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 111:677-690.
13. Ito K, Caramori G, and Adcock IM (2007) Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease. J Pharmacol Exp Ther 321:1-8.
14. Kobayashi T, Hayashi Y, Taguchi K, Matsumoto T, and Kamata K (2006) ANG II enhances contractile responses via PI3-kinase p110 delta pathway in aortas from diabetic rats with systemic hyperinsulinemia. Am J Physiol Heart Circ Physiol 291:H846-H853.
15. Kumar RK, Herbert C, Yang M, Koskinen AM, McKenzie AN, and Foster PS (2002) Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma. Clin Exp Allergy 32:1104-1111.
16. Kuperman DA, Huang X, Koth LL, Chang GH, Dolganov GM, Zhu Z, Elias JA, Sheppard D, and Erle DJ (2002) Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 8:885-889.
17. Kwak YG, Song CH, Yi HK, Hwang PH, Kim JS, Lee KS, and Lee YC (2003) Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J Clin Invest 111:1083-1092.
18. Laporte JC, Moore PE, Baraldo S, Jouvin MH, Church TL, Schwartzman IN, Panettieri RA Jr, Kinet JP, and Shore SA (2001) Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am J Respir Crit Care Med 164:141-148.
19. Lee KS, Lee HK, Hayflick JS, Lee YC, and Puri KD (2006) Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. FASEB J 20:455-465.
20. Levy F, Kristofic C, Heusser C, and Brinkmann V (1997) Role of IL-13 in CD4 T cell-dependent IgE production in atopy. Int Arch Allergy Immunol 112:49-58.
21. Lordan JL, Bucchieri F, Richter A, Konstantinidis A, Holloway JW, Thornber M, Puddicombe SM, Buchanan D, Wilson SJ, Djukanovic R, et al. (2002) Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells. J Immunol 169:407-414.
22. 2+ channels. Circ Res 89:692-699.
23. Medina-Tato DA, Ward SG, and Watson ML (2007) Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond. Immunology 121:448-461.
24. Moffatt JD, Cocks TM, and Page CP (2004) Role of the epithelium and acetylcholine in mediating the contraction to 5-hydroxytryptamine in the mouse isolated trachea. Br J Pharmacol 141:1159-1166.
25. Nashed BF, Zhang T, Al-Alwan M, Srinivasan G, Halayko AJ, Okkenhaug K, Vanhaesebroeck B, HayGlass KT, and Marshall AJ (2007) Role of the phosphoinositide 3-kinase p110 delta in generation of type 2 cytokine responses and allergic airway inflammation. Eur J Immunol 37:416-424.
26. Northcott CA, Hayflick J, and Watts SW (2005) Upregulated function of phosphatidylinositol-3-kinase in genetically hypertensive rats: a moderator of arterial hypercontractility. Clin Exp Pharmacol Physiol 32:851-858.
27. Okkenhaug K, Bilancio A, Farjot G, Priddle H, Sancho S, Peskett E, Pearce W, Meek SE, Salpekar A, Waterfield MD, et al. (2002) Impaired B and T cell antigen receptor signaling in p110 delta PI 3-kinase mutant mice. Science 297:1031-1034.
28. Rizzo CA, Yang R, Greenfeder S, Egan RW, Pauwels RA, and Hey JA (2002) The IL-5 receptor on human bronchus selectively primes for hyperresponsiveness. J Allergy Clin Immunol 109:404-409.
29. Schaafsma D, McNeill KD, Stelmack GL, Gosens R, Baarsma HA, Dekkers BG, Frohwerk E, Penninks JM, Sharma P, Ens KM, et al. (2007) Insulin increases the expression of contractile phenotypic markers in airway smooth muscle. Am J Physiol Cell Physiol 293:C429-C439.
30. Syed F, Panettieri RA Jr, Tliba O, Huang C, Li K, Bracht M, Amegadzie B, Griswold D, Li L, and Amrani Y (2005) The effect of IL-13 and IL-13R130Q, a naturally occurring IL-13 polymorphism, on the gene expression of human airway smooth muscle cells. Respir Res 6:9.
31. Su XL, Smolock EM, Marcel KN, and Moreland RS (2004) Phosphatidylinositol 3-kinase modulates vascular smooth muscle contraction by calcium and myosin light chain phosphorylation-independent and -dependent pathways. Am J Physiol Heart Circ Physiol 286:H657-H666.
32. Tliba O, Deshpande D, Chen H, Van Besien C, Kannan M, Panettieri RA Jr and Amrani Y (2003) IL-13 enhances agonist-evoked calcium signals and contractile responses in airway smooth muscle. Br J Pharmacol 140:1159-1162.
33. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ, and Waterfield MD (2001) Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 70:535-602.
34. Walter DM, McIntire JJ, Berry G, McKenzie ANJ, Donaldson DD, DeKruyff RH, and Umetsu DT (2001) Critical Role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol 167:4668-4675.
35. Ward SG, Reif K, Ley S, Fry MJ, Waterfield MD, and Cantrell DA (1992) Regulation of phosphoinositide kinases in T cells. Evidence that phosphatidylinositol 3-kinase is not a substrate for T cell antigen receptor-regulated tyrosine kinases. J Biol Chem 267:23862-23869.
36. Wills-Karp M (2004) Interleukin-13 in asthma pathogenesis. Immunol Rev 202:175-190.
37. Wright K, Ward SG, Kolios G, and Westwick J (1997) Activation of phosphatidylinositol 3-kinase by interleukin-13. An inhibitory signal for inducible nitric-oxide synthase expression in epithelial cell line HT-29. J Biol Chem 272:12626-12633.
38. Yang M, Hogan SP, Henry PJ, Matthaei KI, McKenzie ANJ, Young IG, Rothenberg ME, and Foster PS (2001) Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin. Am J Respir Cell Mol Biol 25:522-530.
39. Zhu Z, Homer RJ, Wang ZD, Chen QS, Geba GP, Wang JM, Zhang Y, and Elias JA (1999) Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103:779-788.